ロード中...
Considering Patient Preferences When Selecting Anti–Tumor Necrosis Factor Therapeutic Options
BACKGROUND: Anti–tumor necrosis factor (TNF) medications for the treatment of chronic inflammatory conditions represent a large and growing expenditure for health plans. Over the past few years, there has been an increase in options for patients receiving anti-TNFs, including choice of agent, route...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Engage Healthcare Communications, LLC
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4049117/ https://ncbi.nlm.nih.gov/pubmed/24991392 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|